Inspire Medical Systems, Inc. SEC filings INSP
Inspire Medical Systems, Inc. has 897 filings in SEC EDGAR's recent list, going back to May 30, 2014. Its latest annual report, Form ARS, was filed on Mar 20, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 2, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 2, 2026 (results of operations, regulation fd disclosure). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 10-Q | Quarterly report | Nov 2, 2026 | Sep 30, 2026 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Nov 2, 2026 | Nov 2, 2026 |
| 10-Q | Quarterly report | Aug 3, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Aug 3, 2026 | Aug 3, 2026 |
| 8-K |
Current report
Officer or director change
|
Jul 24, 2026 | Jul 20, 2026 |
| 8-K |
Current report
Officer or director change
|
Jul 22, 2026 | Jul 16, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Jun 26, 2026 | Jun 26, 2026 |
| SD | Specialized disclosure (conflict minerals) | Jun 1, 2026 | — |
| S-8 | Employee stock plan registration | May 7, 2026 | — |
| 8-K |
Current report
Officer or director change, Bylaw or fiscal year change, Shareholder vote results
|
May 5, 2026 | Apr 30, 2026 |
| 10-Q | Quarterly report | May 4, 2026 | Mar 31, 2026 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
May 4, 2026 | May 4, 2026 |
| ARS | Annual report to shareholders | Mar 20, 2026 | Dec 31, 2025 |
| DEFA14A | Additional proxy material | Mar 20, 2026 | — |
| DEF 14A | Proxy statement | Mar 20, 2026 | Apr 30, 2026 |
| PRE 14A | Preliminary proxy statement | Mar 9, 2026 | Apr 30, 2026 |
| 10-K | Annual report | Feb 13, 2026 | Dec 31, 2025 |
| 8-K |
Current report
Results of operations, Bylaw or fiscal year change, Regulation FD disclosure
|
Feb 11, 2026 | Feb 5, 2026 |
| 8-K |
Current report
Results of operations, Officer or director change, Regulation FD disclosure
|
Jan 12, 2026 | Jan 9, 2026 |
| 8-K |
Current report
Other events
|
Nov 17, 2025 | Nov 17, 2025 |
| 10-Q | Quarterly report | Nov 3, 2025 | Sep 30, 2025 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Nov 3, 2025 | Nov 3, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Oct 10, 2025 | Oct 10, 2025 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Aug 26, 2025 | Aug 22, 2025 |
| 8-K |
Current report
Other events
|
Aug 11, 2025 | Aug 11, 2025 |
| 10-Q | Quarterly report | Aug 4, 2025 | Jun 30, 2025 |
| 8-K |
Current report
Results of operations, Officer or director change, Regulation FD disclosure
|
Aug 4, 2025 | Aug 4, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Jun 13, 2025 | Jun 13, 2025 |
| SD | Specialized disclosure (conflict minerals) | May 30, 2025 | — |
| 10-Q | Quarterly report | May 5, 2025 | Mar 31, 2025 |
| 8-K |
Current report
Shareholder vote results
|
May 5, 2025 | May 1, 2025 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
May 5, 2025 | May 5, 2025 |
| ARS | Annual report to shareholders | Mar 18, 2025 | Dec 31, 2024 |
| DEFA14A | Additional proxy material | Mar 18, 2025 | — |
| DEF 14A | Proxy statement | Mar 18, 2025 | May 1, 2025 |
| 10-K | Annual report | Feb 10, 2025 | Dec 31, 2024 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Feb 10, 2025 | Feb 10, 2025 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Jan 13, 2025 | Jan 13, 2025 |
| 8-K |
Current report
Other events
|
Nov 12, 2024 | Nov 8, 2024 |
| 10-Q | Quarterly report | Nov 4, 2024 | Sep 30, 2024 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Nov 4, 2024 | Nov 4, 2024 |
| 10-Q | Quarterly report | Aug 6, 2024 | Jun 30, 2024 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure, Other events
|
Aug 6, 2024 | Aug 6, 2024 |
| 8-K |
Current report
Other events
|
Aug 2, 2024 | Aug 2, 2024 |
| 8-K |
Current report
Results of operations
|
Jul 29, 2024 | Jul 29, 2024 |
| 8-K |
Current report
Officer or director change
|
Jul 22, 2024 | Jul 18, 2024 |
| 8-K |
Current report
Shareholder vote results
|
May 7, 2024 | May 7, 2024 |
| 10-Q | Quarterly report | May 7, 2024 | Mar 31, 2024 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
May 7, 2024 | May 7, 2024 |
| ARS | Annual report to shareholders | Mar 19, 2024 | Dec 31, 2023 |
| DEFA14A | Additional proxy material | Mar 19, 2024 | — |
| DEF 14A | Proxy statement | Mar 19, 2024 | May 2, 2024 |
| 10-K | Annual report | Feb 9, 2024 | Dec 31, 2023 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Feb 6, 2024 | Feb 6, 2024 |
| 8-K |
Current report
Officer or director change
|
Feb 5, 2024 | Jan 30, 2024 |
| 8-K |
Current report
Officer or director change
|
Jan 26, 2024 | Jan 22, 2024 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Jan 8, 2024 | Jan 8, 2024 |
| 8-K |
Current report
Officer or director change
|
Dec 28, 2023 | Dec 21, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Nov 7, 2023 | Nov 7, 2023 |
| 10-Q | Quarterly report | Nov 7, 2023 | Sep 30, 2023 |
| 8-K |
Current report
Results of operations
|
Nov 7, 2023 | Nov 7, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Aug 1, 2023 | Aug 1, 2023 |
| 10-Q | Quarterly report | Aug 1, 2023 | Jun 30, 2023 |
| 8-K |
Current report
Results of operations, Officer or director change
|
Aug 1, 2023 | Jul 27, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
May 22, 2023 | May 22, 2023 |
| 8-K |
Current report
Shareholder vote results
|
May 2, 2023 | May 2, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
May 2, 2023 | May 2, 2023 |
| 10-Q | Quarterly report | May 2, 2023 | Mar 31, 2023 |
| 8-K |
Current report
Results of operations
|
May 2, 2023 | May 2, 2023 |
| ARS | Annual report to shareholders | Mar 17, 2023 | Dec 31, 2022 |
| DEFA14A | Additional proxy material | Mar 17, 2023 | — |
| DEF 14A | Proxy statement | Mar 17, 2023 | — |
| 10-K | Annual report | Feb 10, 2023 | Dec 31, 2022 |
| 8-K |
Current report
Regulation FD disclosure
|
Feb 7, 2023 | Feb 7, 2023 |
| 8-K |
Current report
Results of operations
|
Feb 7, 2023 | Feb 7, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 9, 2023 | Jan 9, 2023 |
| 8-K |
Current report
Results of operations
|
Jan 9, 2023 | Jan 9, 2023 |
| 10-Q | Quarterly report | Nov 1, 2022 | Sep 30, 2022 |
| 8-K |
Current report
Results of operations
|
Nov 1, 2022 | Nov 1, 2022 |
| 8-K |
Current report
Agreement ended
|
Aug 24, 2022 | Aug 18, 2022 |
| 8-K |
Current report
Other events
|
Aug 15, 2022 | Aug 11, 2022 |
| 424B5 | Prospectus supplement | Aug 15, 2022 | — |
| 424B5 | Prospectus supplement | Aug 11, 2022 | — |
| 10-Q | Quarterly report | Aug 2, 2022 | Jun 30, 2022 |
| 8-K |
Current report
Results of operations
|
Aug 2, 2022 | Aug 2, 2022 |
| 8-K |
Current report
Officer or director change
|
Aug 2, 2022 | Jul 28, 2022 |
| 8-K |
Current report
Material agreement, New debt
|
Jun 22, 2022 | Jun 15, 2022 |
| 8-K |
Current report
Regulation FD disclosure
|
May 4, 2022 | May 3, 2022 |
| 8-K |
Current report
Shareholder vote results
|
May 3, 2022 | Apr 28, 2022 |
| 10-Q | Quarterly report | May 3, 2022 | Mar 31, 2022 |
| 8-K |
Current report
Results of operations
|
May 3, 2022 | May 3, 2022 |
| DEFA14A | Additional proxy material | Mar 16, 2022 | — |
| DEF 14A | Proxy statement | Mar 16, 2022 | Apr 28, 2022 |
| 10-K | Annual report | Feb 15, 2022 | Dec 31, 2021 |
| 8-K |
Current report
Regulation FD disclosure
|
Feb 10, 2022 | Feb 10, 2022 |
| 8-K |
Current report
Results of operations
|
Feb 8, 2022 | Feb 8, 2022 |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 4, 2022 | Jan 4, 2022 |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 4, 2022 | Jan 4, 2022 |
| 8-K |
Current report
Regulation FD disclosure
|
Nov 3, 2021 | Nov 3, 2021 |
| 10-Q | Quarterly report | Nov 2, 2021 | Sep 30, 2021 |
| 8-K |
Current report
Results of operations
|
Nov 2, 2021 | Nov 2, 2021 |
| 8-K |
Current report
Regulation FD disclosure
|
Aug 4, 2021 | Aug 3, 2021 |
| 10-Q | Quarterly report | Aug 3, 2021 | Jun 30, 2021 |
| 8-K |
Current report
Results of operations
|
Aug 3, 2021 | Aug 3, 2021 |
| 8-K |
Current report
Regulation FD disclosure
|
Jun 7, 2021 | Jun 7, 2021 |
| 8-K |
Current report
Other events
|
May 21, 2021 | May 20, 2021 |
| 8-K |
Current report
Regulation FD disclosure
|
May 5, 2021 | May 4, 2021 |
| 8-K |
Current report
Shareholder vote results
|
May 4, 2021 | Apr 29, 2021 |
| 10-Q | Quarterly report | May 4, 2021 | Mar 31, 2021 |
| 8-K |
Current report
Results of operations
|
May 4, 2021 | May 4, 2021 |
| DEFA14A | Additional proxy material | Mar 16, 2021 | — |
| DEF 14A | Proxy statement | Mar 16, 2021 | Apr 29, 2021 |
| 8-K |
Current report
Regulation FD disclosure
|
Feb 24, 2021 | Feb 23, 2021 |
| 10-K | Annual report | Feb 24, 2021 | Dec 31, 2020 |
| 8-K |
Current report
Results of operations
|
Feb 23, 2021 | Feb 23, 2021 |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 7, 2021 | Jan 7, 2021 |
| 8-K |
Current report
Regulation FD disclosure
|
Nov 9, 2020 | Nov 9, 2020 |
| 10-Q | Quarterly report | Nov 2, 2020 | Sep 30, 2020 |
| 8-K |
Current report
Results of operations
|
Nov 2, 2020 | Nov 2, 2020 |
| 8-K |
Current report
Officer or director change
|
Oct 22, 2020 | Oct 20, 2020 |
| 8-K |
Current report
Regulation FD disclosure
|
Aug 5, 2020 | Aug 5, 2020 |
| 10-Q | Quarterly report | Aug 4, 2020 | Jun 30, 2020 |
| 8-K |
Current report
Results of operations
|
Aug 4, 2020 | Aug 4, 2020 |
| 8-K |
Current report
Officer or director change
|
Jul 10, 2020 | Jul 7, 2020 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Jun 8, 2020 | Jun 8, 2020 |
| 8-K |
Current report
Regulation FD disclosure
|
May 6, 2020 | May 5, 2020 |
| 10-Q | Quarterly report | May 5, 2020 | Mar 31, 2020 |
| 8-K |
Current report
Results of operations
|
May 5, 2020 | May 5, 2020 |
| 8-K |
Current report
Shareholder vote results
|
May 4, 2020 | Apr 30, 2020 |
| 8-K |
Current report
Other events
|
Apr 16, 2020 | Apr 13, 2020 |
| 424B5 | Prospectus supplement | Apr 15, 2020 | — |
| 424B5 | Prospectus supplement | Apr 13, 2020 | — |
| 8-K |
Current report
Results of operations, Other events
|
Apr 13, 2020 | Apr 13, 2020 |
| S-3ASR | Automatic shelf registration | Apr 13, 2020 | — |
| DEFR14A | Filing | Mar 17, 2020 | — |
| DEFA14A | Additional proxy material | Mar 16, 2020 | — |
| DEF 14A | Proxy statement | Mar 16, 2020 | Apr 30, 2020 |
| 8-K |
Current report
Regulation FD disclosure
|
Feb 26, 2020 | Feb 26, 2020 |
| 10-K | Annual report | Feb 25, 2020 | Dec 31, 2019 |
| 8-K |
Current report
Results of operations
|
Feb 25, 2020 | Feb 25, 2020 |
| 8-K |
Current report
Regulation FD disclosure
|
Nov 12, 2019 | Nov 12, 2019 |
| 10-Q | Quarterly report | Nov 5, 2019 | Sep 30, 2019 |
| 8-K |
Current report
Results of operations
|
Nov 5, 2019 | Nov 5, 2019 |
| 8-K |
Current report
Regulation FD disclosure
|
Sep 4, 2019 | Sep 4, 2019 |
| 10-Q | Quarterly report | Aug 6, 2019 | Jun 30, 2019 |
| 8-K |
Current report
Results of operations
|
Aug 6, 2019 | Aug 6, 2019 |
| 8-K |
Current report
Officer or director change
|
Jul 29, 2019 | Jul 25, 2019 |
| 8-K |
Current report
Regulation FD disclosure
|
May 9, 2019 | May 9, 2019 |
| 8-K |
Current report
Shareholder vote results
|
May 8, 2019 | May 2, 2019 |
| 10-Q | Quarterly report | May 7, 2019 | Mar 31, 2019 |
| 8-K |
Current report
Results of operations
|
May 7, 2019 | May 7, 2019 |
| 8-K |
Current report
Material agreement, New debt
|
Mar 29, 2019 | Mar 27, 2019 |
| DEFA14A | Additional proxy material | Mar 20, 2019 | — |
| DEF 14A | Proxy statement | Mar 20, 2019 | May 2, 2019 |
| 8-K |
Current report
Regulation FD disclosure
|
Feb 27, 2019 | Feb 27, 2019 |
| 10-K | Annual report | Feb 26, 2019 | Dec 31, 2018 |
| 8-K |
Current report
Regulation FD disclosure
|
Feb 26, 2019 | Feb 26, 2019 |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 7, 2019 | Jan 7, 2019 |
| 424B4 | Prospectus | Dec 7, 2018 | — |
| EFFECT | Filing | Dec 6, 2018 | — |
| CORRESP | Letter to the SEC | Dec 4, 2018 | — |
| CORRESP | Letter to the SEC | Dec 4, 2018 | — |
| S-1 | Registration statement | Dec 4, 2018 | — |
| UPLOAD | Letter from the SEC | Dec 3, 2018 | — |
| DRS | Filing | Nov 21, 2018 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Nov 13, 2018 | Nov 13, 2018 |
| 10-Q | Quarterly report | Nov 6, 2018 | Sep 30, 2018 |
| 8-K |
Current report
Results of operations
|
Nov 6, 2018 | Nov 6, 2018 |
| 8-K |
Current report
Regulation FD disclosure
|
Oct 2, 2018 | Oct 2, 2018 |
| 8-K |
Current report
Regulation FD disclosure
|
Sep 5, 2018 | Sep 5, 2018 |
| 10-Q | Quarterly report | Aug 7, 2018 | Jun 30, 2018 |
| 8-K |
Current report
Results of operations
|
Aug 7, 2018 | Aug 7, 2018 |
| 10-Q | Quarterly report | Jun 7, 2018 | Mar 31, 2018 |
| S-8 | Employee stock plan registration | May 8, 2018 | — |
| 8-K |
Current report
Bylaw or fiscal year change
|
May 7, 2018 | May 7, 2018 |
| 424B4 | Prospectus | May 4, 2018 | — |
| EFFECT | Filing | May 2, 2018 | — |
| FWP | Free writing prospectus | May 2, 2018 | — |
| S-1/A | Amended registration statement | May 2, 2018 | — |
| CORRESP | Letter to the SEC | Apr 30, 2018 | — |
| CORRESP | Letter to the SEC | Apr 30, 2018 | — |
| CERT | Nyse certification - inspire medical systems, inc. | Apr 25, 2018 | — |
| 8-A12B | Filing | Apr 24, 2018 | — |
| S-1/A | Amended registration statement | Apr 23, 2018 | — |
| CORRESP | Letter to the SEC | Apr 13, 2018 | — |
| S-1 | Registration statement | Apr 6, 2018 | — |
| DRS/A | Filing | Mar 19, 2018 | — |
| DRSLTR | Filing | Mar 19, 2018 | — |
| UPLOAD | Letter from the SEC | Mar 13, 2018 | — |
| DRS | Filing | Feb 14, 2018 | — |
| D | Filing | Nov 8, 2016 | — |
| D | Filing | May 30, 2014 | — |
Showing 192 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Surgical & Medical Instruments & Apparatus (SIC 3841)
- Listed as
- INSP (NYSE)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Golden Valley, MN
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1609550
Other Surgical & Medical Instruments & Apparatus companies
- Stryker Corp SYK
- 3M Co MMM
- Boston Scientific Corp BSX
- Becton Dickinson & Co BDX
- Medline Inc. MDLN
- Resmed Inc RMD
- Dexcom Inc DXCM
- Fresenius SE & Co. KGaA FSNUY
All 151 Surgical & Medical Instruments & Apparatus companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.